{
    "name": "2024-10-24-04-15-42-678",
    "cls": "诊断学",
    "numb": "53",
    "unit": "第四篇 第八章 临床常用免疫学检测",
    "mode": "A1",
    "test": "应选择下列哪组肿瘤标志物进行联合检测诊断胰腺癌",
    "option": [
        "A.CEA+AFP+CA125+CA199",
        "B.CEA+AFP+CA724+CA125",
        "C.CEA+CA199+CA50+CA242",
        "D.PSA+PAP+AFP+CA125",
        "E.AFP+PSA+SCC+CA199"
    ],
    "answer": "C",
    "point": "（P422）“表 4-8-3肿瘤标志物的选择”（C对）。",
    "discuss": "胰腺癌时，肿瘤标志物的选择：CA199为首选，CA50和CA242为次选，CEA为补充次选。故诊断胰腺癌应选择CEA+CA199+CA50+CA242（C对）进行联合检测。"
}